MAPT and Alzheimer disease: AD RT-QuIC is also capable of amplifying the 3R/4R tau aggregates that occur in primary age-related tauopathy (PART), a largely non-clinical pathological description of tau aggregates that accumulate as part of an aging process in the absence of Aβ deposits [70].